Adjuvant chemotherapy versus perioperative chemotherapy (CTx) for resectable gastric signet ring cell (SRC) gastric cancer: A multicenter, randomized phase II study (PRODIGE 19).

被引：24

作者：

Eveno, Clarisse

Adenis, Antoine

Bouche, Olivier

Le Malicot, Karine

Hautefeuille, Vincent

Faroux, Roger

Bidault, Anne Thirot

Egreteau, Joelle

Meunier, Bernard

Mabro, May

Carrere, Nicolas

Barriere, Nicolas

Ben Abdelghani, Meher

Mauvais, Francois

Di Fiore, Frederic

Malka, David

Manfredi, Sylvain

Piessen, Guillaume

机构：

[1] CHRU Lille, Lille, France

[2] Inst Canc Montpellier, Montpellier, France

[3] CHU Robert Debre, Reims, France

[4] FFCD, Dijon, France

[5] INSERM U1231, Dijon, France

[6] Amiens Univ Hosp, Amiens, France

[7] Ctr Hosp Dept Oudairies, La Roche Sur Yon, France

[8] Hop Prive Antony, Antony, France

[9] Ctr Hospitalier Bretagne Sud, Lorient, France

[10] Pontchaillou Univ Hosp, Rennes, France

[11] Hop Foch, Suresnes, France

[12] Purpan Univ Hosp, Dept Digest Surg, Toulouse, France

[13] Hop Europeen, Marseille, France

[14] Ctr Paul Strauss, Strasbourg, France

[15] CH Beauvais, Beauvais, France

[16] Rouen Univ Hosp, Dept Hepato Gastroenterol, Digest Oncol Unit, Rouen, France

[17] Univ Paris Saclay, Dept Med Oncolog, Gustave Roussy, Villejuif, France

[18] CHU La Bocage HGE, Dijon, France

[19] Univ Hosp Lille, Lille, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.4019

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4019

引用

页数：1